Manufacturer Profile

GlaxoSmithKline plc (LSE: GSK NYSE: GSK) is a United Kingdom-based pharmaceutical, biological, and healthcare company. GSK is the world's second largest pharmaceutical company and a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

GlaxoSmithKline Inc. (GSK) is a world leading research-based pharmaceutical company devoted to discovering and developing new and innovative medicines and vaccines for Canadians and people around the world. Every day, our employees strive to improve the quality of human life by enabling people to do more, feel better and live longer.

GSK in Canada's Business Development Team identifies and evaluates opportunities, including the acquisition and in-licensing of new products and services, to expand and diversify the company's portfolio.

GSK produces medicines for five major disease areas - respiratory illness, diabetes, virus control, infections and central nervous system disorders. In addition, we are a leader in the important area of vaccines and are developing new treatments for cancer.

The company is also Canada's leading flu vaccine manufacturer and supplies 75 per cent of Canadian government seasonal flu vaccine purchases.